Dissecting the association between metabolic syndrome and prostate cancer risk: analysis of a large clinical cohort.
about
Leptin signalling, obesity and prostate cancer: molecular and clinical perspective on the old dilemmaNutrition, dietary interventions and prostate cancer: the latest evidenceMetabolic syndrome is associated with advanced prostate cancer in patients treated with radical retropubic prostatectomy: results from a multicentre prospective studyLow serum total testosterone level as a predictor of upstaging and upgrading in low-risk prostate cancer patients meeting the inclusion criteria for active surveillance.Associations among Metabolism, Circadian Rhythm and Age-Associated DiseasesHighlights of the university of toronto urology update 2014.Metabolic syndrome and prostate cancer risk in a population-based case-control study in Montreal, CanadaMetabolic syndrome-like components and prostate cancer risk: results from the Reduction by Dutasteride of Prostate Cancer Events (REDUCE) studyThe association between metabolic syndrome and advanced prostate cancer in Chinese patients receiving radical prostatectomyStructural and Functional Evidence for Testosterone Activation of GPRC6A in Peripheral TissuesEvidence for Osteocalcin Binding and Activation of GPRC6A in β-CellsAssociation between baseline serum glucose, triglycerides and total cholesterol, and prostate cancer risk categoriesHypertension and risk of prostate cancer: a systematic review and meta-analysisEffects of Serum Triglycerides on Prostate Cancer and Breast Cancer Risk: A Meta-Analysis of Prospective Studies.Metabolic syndrome in prostate cancer: impact on risk and outcomesInsulin, insulin receptors, and cancer.Meta-analysis of metabolic syndrome and prostate cancer.The Association between Phosphodiesterase Type 5 Inhibitors and Prostate Cancer: Results from the REDUCE StudyMetabolic syndrome, dyslipidemia and prostate cancer recurrence after primary surgery or radiation in a veterans cohort.Overexpression and knock-down studies highlight that a disintegrin and metalloproteinase 28 controls proliferation and migration in human prostate cancer.Modern-day prostate cancer is not meaningfully associated with lower urinary tract symptoms: Analysis of a propensity score-matched cohort.Long-term supplementation of decaffeinated green tea extract does not modify body weight or abdominal obesity in a randomized trial of men at high risk for prostate cancer.Metabesity and urological cancers.Investigating the role of the IGF axis as a predictor of biochemical recurrence in prostate cancer patients post-surgery.Midlife metabolic factors and prostate cancer risk in later life.
P2860
Q26786149-7BC0DBB8-E42B-4AF6-B199-39B4FD48E94FQ28084566-804EB6DF-A509-41CF-AEAC-798AA6E14CDAQ28596648-17BEFC6A-586E-41B5-851F-24F40ABF1A88Q33566981-7FFFFD7E-82EA-49AD-B655-AB0B2F157B6AQ33714257-79F2806E-8925-4A8A-B025-0DC4A527C7A7Q35100023-5060BC40-78C2-4125-9651-B022CAAB371EQ35781093-96BC8621-BCA5-4D90-9AD4-AF8302092EEFQ36044730-B2E18EF2-440C-413B-97DE-456BF1061C33Q36080375-4B2EE6E7-35B6-4C8C-ADC9-565C5D440C14Q36331791-1BB172AE-5C4F-4B2C-AEFB-96A14020A657Q36911581-A924716B-8EBA-4BB8-A758-8F1D8130C51BQ37045608-F10EB7EC-D1E9-4B3A-8B85-1CCB796133F3Q37166965-BF988782-1CA7-4AE4-845C-3A6E6CB8C7DDQ38377423-F6122C87-6320-4C7A-B919-08DA0875FAE1Q38805127-087F7AA1-DA67-4F4E-8FD3-1D51613BC471Q38883620-E87AB85A-9646-4144-BD98-5AB91A35EF31Q39145052-5B79767A-15F4-4093-9BBC-BDB76300C9BCQ41036693-8B30E0E0-03E0-4395-A98F-296EA8A89004Q41139603-69779EAD-6C6D-4A03-B7C0-A3860688EB32Q41425790-4481600F-2E32-4BDA-AB3D-F5AEC976A304Q42021362-23B7559E-3FCB-486B-A0F0-63B41176838DQ47107153-3712B685-B522-4F8B-B891-6E32CE221AC1Q47139943-BA19FFCB-32FD-4F39-9A4B-771F343346ADQ47758797-AC76D4DA-05EC-4624-89BD-290F2CA7FE91Q48346823-390862D6-ED51-4251-86CB-A407DB941F7C
P2860
Dissecting the association between metabolic syndrome and prostate cancer risk: analysis of a large clinical cohort.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh-hant
name
Dissecting the association bet ...... is of a large clinical cohort.
@en
Dissecting the association bet ...... is of a large clinical cohort.
@nl
type
label
Dissecting the association bet ...... is of a large clinical cohort.
@en
Dissecting the association bet ...... is of a large clinical cohort.
@nl
prefLabel
Dissecting the association bet ...... is of a large clinical cohort.
@en
Dissecting the association bet ...... is of a large clinical cohort.
@nl
P2093
P1433
P1476
Dissecting the association bet ...... is of a large clinical cohort.
@en
P2093
Alexandre R Zlotta
Andrew Evans
Antonio Finelli
Bimal Bhindi
David S Margel
Girish S Kulkarni
Jennifer Locke
John Trachtenberg
Karen M Hersey
P356
10.1016/J.EURURO.2014.01.040
P407
P577
2014-02-14T00:00:00Z